The value of Spin-outs by Martin Bonde, Chairman Dansk Biotek and Copenhagen Spin-outs

What is the societal value of public biotech Spin-outs? Where is the link to industry and how should central administration support it? Martin Bonde explains what it takes to make it and what value it provides.